Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole effects on the intestinal microbiome in healthy volunteers
NL-OMON60533Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluconazole (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in gut bacteriome and mycobiome composition at day 14. Started Jan 2026; status: recruiting.
02
Drugs
fluconazole
Beyond the preview
Go deeper on NL-OMON60533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60533.